Vitamin producer Blackmores has announced an equity raising of up to $117 million to strengthen its balance sheet during the coronavirus crisis, but executive director Marcus Blackmore won't be participating.
Vitamin company Blackmores has scrapped its interim dividend and slashed its full-year profit guidance, blaming it on adverse costs and the coronavirus outbreak.